#7 The challenge of rare diseases – Christina Ström Möller
Listen now
Christina Ström Möller from Swedish biopharmaceutical company Sobi discusses the challenges of developing orphan drugs for rare diseases.
More Episodes
Published 12/15/22
The COVID-19 pandemic forced pharmacovigilance experts to revisit their processes to deal with unprecedented volumes of data and catch unexpected safety issues. Elena Rocca from Oslo Metropolitan University reviews the challenges of a global healthcare emergency – and what it can teach us about...
Published 12/15/22